Response to Calcagno comment on "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid"

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):e14-5. doi: 10.1097/QAI.0b013e3182a82281.

Authors

Alexia Cusini¹, Bruno Ledergerber, Nicolas Widmer, Huldrych F Günthard

Affiliation

¹ *Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland †Department of Infectious Diseases, University Hospital Bern, Bern, Switzerland ‡Division of Clinical Pharmacology, University Hospital Centre and University of Lausanne, Lausanne, Switzerland.

PMID: 24047974
DOI: 10.1097/QAI.0b013e3182a82281

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anti-Retroviral Agents / administration & dosage*
Anti-Retroviral Agents / pharmacokinetics*
Antiretroviral Therapy, Highly Active / methods*
Cerebrospinal Fluid / virology*
Female
HIV Infections / drug therapy*
HIV-1 / isolation & purification*
Humans
Male
Viral Load*

Substances

Anti-Retroviral Agents